COMPARING CARDIOVASCULAR EVENT RATES OF STATIN PLUS FIBRATE COMBINATION THERAPY WITH STATIN MONOTHERAPY IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS

被引：0
|
作者：
Suh, H. S. [1 ]
Doctor, J. N. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73770-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A141 / A142
页数：2
相关论文
共 50 条
  • [41] The Association of Statin Therapy with Liver and Pancreatic Fat Fraction in Type 2 Diabetes Mellitus
    Parlar, Mehmet Akif
    Mutlu, Hakan
    Dogantekin, Betul
    Musaoglu, Ismail Serhat
    Albayrakoglu, Nisa Demirbosnak
    Yavuz, Mustafa Lutfi
    Ozbolat, Zehra Busra
    Kaplan, Mustafa
    DIAGNOSTICS, 2025, 15 (04)
  • [42] Risk of type 2 diabetes mellitus associated with statin therapy: evidence and possible mechanisms
    Suazo, Jose
    Rigotti, Attilio
    REVISTA MEDICA DE CHILE, 2014, 142 (02) : 222 - 228
  • [43] STATIN THERAPY FOR DYSLIPIDEMIA AND CORONARY HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Cozma, M. A.
    Gaman, M. A.
    Dobrica, E. C.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E250 - E251
  • [44] Statin plus fibrate combination therapy-fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease
    Wray, R
    Hemsley, D
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 71 (03) : 291 - 291
  • [45] Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors
    Go, Alan S.
    Ambrosy, Andrew P.
    Kheder, Kevin
    Fan, Dongjie
    Sung, Sue Hee
    Inveiss, Alda I.
    Romo-LeTourneau, Victoria
    Thomas, Sheila M.
    Koren, Andrew
    Lo, Joan C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 534 - 541
  • [46] Cardiovascular event reduction after treatment initiation with simvastatin plus niacin extendedrelease combination therapy versus statin monotherapy among managed care dyslipidemia patients
    Simko, R.
    Quimbo, R.
    Cziraky, M.
    Balu, S.
    EUROPEAN HEART JOURNAL, 2009, 30 : 368 - 368
  • [47] Comparison of High-potency Statin Monotherapy and Statin Plus Ezetimibe Combination Therapy for Reducing Cardio-cerebrovascular Disease Risk
    Yang, Bo Ram
    Lee, Joongyub
    Choi, Nam-Kyong
    Shin, Ju-Young
    Chang, Yoosoo
    Song, Hong-Ji
    Youn, KyungEun
    Jin, Xue-Mei
    Kim, Mi-Sook
    Kim, Ye-Jee
    Seong, Jong-Mi
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 384 - 385
  • [48] Alogliptin plus Metformin Combination Therapy vs. Alogliptin or Metformin Monotherapy for Type 2 Diabetes Mellitus
    Pratley, Richard
    Wilson, Craig
    Fleck, Penny
    DIABETES, 2012, 61 : A299 - A299
  • [49] Remnant Cholesterol as a Residual Risk in Patients With Atherosclerotic Cardiovascular Disease Under ModerateIntensity Statin With Ezetimibe Combination Therapy or HighIntensity Statin Monotherapy
    Lee, Jung-Hee
    Ahn, Sung Gyun
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Ko, Young-Guk
    Kim, Jung-Sun
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Byeong-Keuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B97 - B98
  • [50] Effect of Statin Therapy on Diabetes Retinopathy in People With Type 2 Diabetes Mellitus: A Meta-Analysis
    Liu, Jun
    Wu, Yi-Ping
    Qi, Jun-Juan
    Yue, Zeng-Ping
    Hu, Cheng-Dong
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
12345